BioMark to present at MSACL 2026 and BIOHorizon 2026
BioMark Diagnostics said it will participate in the MSACL 2026 and BIOHorizon 2026 life sciences conferences, including an update on clinical translation of its biomarker platform and a showcase of industry collaborations supporting scalable, high-throughput mass spectrometry.